South Africa Rejects 2m J&J Vaccines Due to FDA Decision

By MOGOMOTSI MAGOME

JOHANNESBURG (AP) — South Africa’s COVID-19 vaccine rollout has been hit by further delays as it will have to discard at least 2 million Johnson & Johnson vaccines produced in the country.

The vaccines were found by the U.S Food and Drug Administration to be unsuitable for use due to possible contamination of their ingredients at a Baltimore plant. South Africa was expecting to use them to inoculate its health care workers and people aged 60 years and older.

This is the latest setback to South Africa’s vaccine rollout which has so far given shots to just over 1% of its 60 million people.

Early this year the country rejected about 1 million doses of the AstraZeneca vaccine it received from the Serum Institute of India after a small, preliminary study found that the vaccine offered minimal protection against mild to moderate cases of the COVID-19 variant that is dominant in South Africa. Those vaccines were sold to the African Union for distribution to other African countries.

To date, the country has given jabs to more than 1.7 million people, including nearly 480,000 health workers who were inoculated as part of a study trial of the Johnson & Johnson vaccine.

The production of the J&J vaccine at South Africa’s Aspen Pharmacare manufacturing plant in the eastern city of Gqeberha, formerly known as Port Elizabeth, was eagerly awaited to give a much-needed boost to the country’s vaccination drive. The factory has contracted with J&J to produce the vaccine using large batches of the basic ingredients supplied by Johnson & Johnson. The South African plant then blends those components and puts them in vials - a process knowns as “fill and finish.”

The South African plant has the capacity to produce about 200 million doses annually of the J&J vaccine and had already manufactured 2 million. But they were produced using ingredients from the Baltimore plant and therefore must not be used, according to the ruling by the FDA and South Africa’s health officials.

The South African Health Products Regulatory Authority issued a statement saying it had “reviewed the data provided by the FDA and has made a decision not to release vaccines produced using the drug substance batches that were not suitable.”

South Africa will now only receive 300,000 doses of the J&J vaccine which have been cleared by the FDA, it said.

Aspen will begin production of new J&J vaccines using fresh, uncontaminated ingredients at its facility this week, President Cyril Ramaphosa announced this week.

South Africa has purchased and is expecting delivery of 30 million doses of the Pfizer vaccine and 31 million single-shot Johnson & Johnson vaccines by early 2022. These deliveries are necessary for South Africa to achieve its goal of vaccinating 40 million people by February 2022.

South Africa is currently experiencing a new resurgence of the COVID-19 pandemic with an increased number of recorded infections. Its 7-day rolling average of daily new cases has more than doubled over the past two weeks from 5.69 new cases per 100,000 people on May 30 to 12.17 new cases per 100,000 people on June 13.

It recorded 7,657 new infections and 59 deaths in the last 24 hours, bringing to 57, 765 the number of people who have died from the virus.

South Africa has been the hardest hit by COVID-19 on the continent, with more than 1.7 million confirmed cases, representing nearly 40% of the more than 5 million cases reported by Africa’s 54 countries.



No comments

Thank you for reaching out to us. We are happy to receive your opinion and request. If you are need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
WHAT KIND OF SPONSORED POSTS DO WE ACCEPT?
Generally, a sponsored post can be any of the following:
Press release
Advertorial
Video content
Article
Interview
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
DURATION & BONUSES
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.

We will also try as much as possible to optimize your post for search engines as well.

Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
PRICING
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $60 per article.

2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.

Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.

Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to omodjk(at)gmail(dot)com

Normally, we should respond within 48 hours.